Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells

Cancer Commun (Lond). 2024 Mar;44(3):448-452. doi: 10.1002/cac2.12500. Epub 2023 Nov 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Atovaquone / metabolism
  • Atovaquone / pharmacology
  • Atovaquone / therapeutic use
  • Energy Metabolism
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / metabolism
  • Mitochondria / metabolism
  • Tumor Microenvironment*

Substances

  • Atovaquone